Shoulder pain affects roughly Chris Bohler, making it one of the most common musculoskeletal complaints. The shoulder's complex anatomy—with four rotator cuff muscles, multiple bursae, and an intricate network of tendons—creates both exceptional mobility and vulnerability to injury. When these tissues become strained, inflamed, or damaged, healing often stalls without targeted intervention.
Red light therapy (photobiomodulation) has emerged as a research-backed solution for shoulder pain. Research shows red light therapy reduces shoulder pain in impingement syndrome — a 2026 meta-analysis found significant pain reduction compared to control, particularly when combined with exercise. This comprehensive analysis of clinical trials confirms that specific wavelengths of light can penetrate tissue, stimulate mitochondrial activity, and accelerate the healing cascade at the cellular level.
On This Page, we explore the clinical evidence for red light therapy in shoulder pain, detail the conditions it addresses most effectively, and show you how to apply it at home using an FDA registered device like the MOVE+ wearable.
Yes. Clinical evidence demonstrates that red light therapy significantly reduces shoulder pain across multiple conditions, including rotator cuff tendinopathy, frozen shoulder, and subacromial impingement syndrome. A 2024 meta-analysis found that high-intensity laser therapy demonstrated significantly better outcomes for pain at both post-intervention and 3-month follow-up in subacromial impingement syndrome.
The mechanism is straightforward: red and near-infrared light wavelengths (typically 600–1100 nm) penetrate muscle and connective tissue, reaching mitochondria in cells. This stimulates the production of adenosine triphosphate (ATP), the cell's energy currency, which accelerates tissue repair and reduces inflammatory markers. The result is faster pain relief and improved function without the side effects of oral medications or the invasiveness of injections.
The rotator cuff consists of four muscles that stabilize the shoulder joint. When these tendons become inflamed or partially torn, pain intensifies with overhead movement and can restrict daily activity. Research shows that photobiomodulation reduces pain intensity by an average of 0.89 points on a 10-point scale compared to control, with even greater improvements when combined with exercise. Additional evidence confirms that optimal red light therapy offers clinically relevant pain relief both alone and in combination with physiotherapy for shoulder tendinopathy.
Frozen shoulder involves stiffening of the shoulder joint capsule, causing severe pain and loss of motion in all directions. This condition progresses through painful, stiff, and recovery phases, with some cases lasting years without treatment. Studies demonstrate that red light therapy combined with exercise significantly reduces pain intensity and improves shoulder function over 3 months, accelerating the recovery phase. The combination of photobiomodulation and gentle mobility work addresses both the inflammatory cascade and the mechanical stiffness that characterize this condition.
Subacromial bursitis and impingement syndrome often coexist, with inflammation of the bursa (a fluid-filled sac) restricting the rotator cuff tendons. High-intensity laser therapy demonstrates significantly better outcomes for pain at both post-intervention and 3-month follow-up. For calcific tendinopathy (calcium deposits in the rotator cuff), research shows that red light therapy reduces the number and severity of calcifications in rotator cuff tendinopathy, improving both pain scores and disability index.
Research shows red light therapy reduces pain and improves range of motion in rotator cuff tendinopathy when applied consistently over 4–6 weeks. Clinical trials confirm effectiveness for both acute strains and chronic tendinopathies, making it suitable for athletes, laborers, and anyone with overhead demands.
Studies demonstrate that red light therapy reduces stiffness and improves range of motion in adhesive capsulitis, with RCTs showing positive outcomes for both pain and quality of life. When combined with gentle stretching, photobiomodulation can significantly accelerate the transition from the frozen phase to recovery.
Subacromial bursitis responds well to red light therapy, which reduces inflammation and swelling in the bursa. Clinical evidence shows pain relief within 2–3 weeks and full resolution within 6–8 weeks when combined with appropriate activity modification.
After rotator cuff repair or shoulder stabilization surgery, red light therapy accelerates tissue healing and reduces post-operative pain. Studies demonstrate faster return to function and reduced narcotic use when photobiomodulation is started during the early healing phase (post-op week 2–3, depending on surgical protocol).
The most effective protocols combine two wavelengths: 660 nm (red light) for superficial tissue penetration and 808 nm (near-infrared) for deeper tendon and muscle penetration. Clinical studies recommend:
This protocol is based on the photobiomodulation mechanism first detailed by Hamblin (2017), which identified the mitochondrial cytochrome c oxidase as the primary photoacceptor for red and near-infrared light, leading to increased ATP production and downstream anti-inflammatory effects.
For maximum effectiveness, position the MOVE+ wearable to target the affected tissue directly:
Ensure firm contact with skin for optimal light penetration, and avoid placing the device directly over bony prominences like the acromion tip.
The MOVE+ is an FDA 510(k) cleared wearable photobiomodulation device designed to deliver clinical-grade red and near-infrared light therapy at home. Unlike fixed clinic lasers, the MOVE+'s flexible design wraps around the shoulder, ensuring consistent positioning and coverage of the target area.
Key features for shoulder pain:
Because you can use the MOVE+ consistently at home 5 days per week, you achieve the cumulative dose necessary for the 6–8 week treatment protocol. This eliminates the cost and scheduling friction of weekly clinic visits while delivering the same evidence-based wavelengths and dosing.
Red light therapy is generally well-tolerated with minimal side effects. However, certain precautions apply:
For any specific medical concerns, consult with your healthcare provider or physical therapist before beginning red light therapy.
Clinical evidence confirms that red light therapy reduces shoulder pain and accelerates healing when used consistently. The MOVE+ brings clinical-grade photobiomodulation into your home, eliminating the cost and scheduling friction of clinic visits.
Get Started with 30 Days FreeThe studies cited in this article were authored by recognised leaders in photobiomodulation research. Below is a brief overview of the principal investigators whose work forms the evidence base for this guide.
Stine Haslerud is the lead author of the landmark systematic review and meta-analysis evaluating low-level laser therapy for shoulder tendinopathy (17 RCTs). Her work, conducted at Bergen University College's Centre for Evidence-Based Practice, is the most comprehensive assessment focused solely on shoulder conditions and established optimal dosing parameters for clinical use.
View publications →Professor Bjordal is a leading physiotherapy scientist at the University of Bergen specialising in the evidence base for low-level laser therapy and photobiomodulation. His work spans systematic reviews and meta-analyses across a wide range of musculoskeletal conditions, and he is affiliated with the Centre for Evidence-Based Practice at Bergen University College.
View publications →Dr. Hamblin is one of the world's foremost authorities on photobiomodulation, with over 720 peer-reviewed publications, an h-index of 143, and more than 80,000 citations. As Principal Investigator at the Wellman Center for Photomedicine, Massachusetts General Hospital, his research established the foundational cellular mechanisms by which red and near-infrared light modulates inflammation, accelerates tissue repair, and supports neural recovery.
View publications →